Specializing in the development and manufacture of innovative new chemical entities, biologicals, and live biotherapeutics for global markets.
SGS is pleased to welcome into our group Quay Pharmaceuticals Limited (Quay Pharma) – a provider of innovative, formulation research and development services for the global biopharmaceutical sector.
This adds to our increasing scope of services to support our customers across the health science supply chain. Quay Pharma will become our global Center of Excellence for Formulation, and Clinical Manufacturing, strengthening our comprehensive portfolio of clinical research and analytical services, and enabling us to better serve the needs of the health science industry.